Search alternatives:
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
greater decrease » greater increase (Expand Search), greater disease (Expand Search), rate decreased (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
greater decrease » greater increase (Expand Search), greater disease (Expand Search), rate decreased (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
-
7081
Image 1_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.jpeg
Published 2025“…Recent genetic-based therapies, such as nusinersen, have transformed disease outcomes. We aimed to evaluate the long-term effects of nusinersen on motor, bulbar, and respiratory functions in both symptomatic and presymptomatic SMA Type 1 patients over a period of up to 4 years.…”
-
7082
Table 7_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.docx
Published 2025“…Recent genetic-based therapies, such as nusinersen, have transformed disease outcomes. We aimed to evaluate the long-term effects of nusinersen on motor, bulbar, and respiratory functions in both symptomatic and presymptomatic SMA Type 1 patients over a period of up to 4 years.…”
-
7083
Table 6_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.docx
Published 2025“…Recent genetic-based therapies, such as nusinersen, have transformed disease outcomes. We aimed to evaluate the long-term effects of nusinersen on motor, bulbar, and respiratory functions in both symptomatic and presymptomatic SMA Type 1 patients over a period of up to 4 years.…”
-
7084
Table 2_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.docx
Published 2025“…Recent genetic-based therapies, such as nusinersen, have transformed disease outcomes. We aimed to evaluate the long-term effects of nusinersen on motor, bulbar, and respiratory functions in both symptomatic and presymptomatic SMA Type 1 patients over a period of up to 4 years.…”
-
7085
Data Sheet 1_Extracorporeal photopheresis as induction therapy in lung transplantation for cystic fibrosis: a pilot randomized trial.docx
Published 2025“…Exploratory endpoint analyses revealed significant decreases in pro-inflammatory cytokines, degranulating CD8<sup>+</sup> T lymphocytes, and NK cells in the treatment group. …”
-
7086
Table 4_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.docx
Published 2025“…Recent genetic-based therapies, such as nusinersen, have transformed disease outcomes. We aimed to evaluate the long-term effects of nusinersen on motor, bulbar, and respiratory functions in both symptomatic and presymptomatic SMA Type 1 patients over a period of up to 4 years.…”
-
7087
Table 3_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.docx
Published 2025“…Recent genetic-based therapies, such as nusinersen, have transformed disease outcomes. We aimed to evaluate the long-term effects of nusinersen on motor, bulbar, and respiratory functions in both symptomatic and presymptomatic SMA Type 1 patients over a period of up to 4 years.…”
-
7088
Table 5_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.docx
Published 2025“…Recent genetic-based therapies, such as nusinersen, have transformed disease outcomes. We aimed to evaluate the long-term effects of nusinersen on motor, bulbar, and respiratory functions in both symptomatic and presymptomatic SMA Type 1 patients over a period of up to 4 years.…”
-
7089
Supplementary file 1_Persistent burden and health inequalities of disease in women of childbearing age attributable to Intimate Partner Violence, 1990–2021.docx
Published 2025“…Aims<p>Intimate Partner Violence (IPV) presents a significant global public health issue, particularly affecting women of childbearing age (WBCA). …”
-
7090
Table 1_Genetic susceptibility to gestational diabetes and its mild modification by bisphenol A and thyroid-stimulating hormone: findings from a South Chinese pregnancy cohort.docx
Published 2025“…The modification displayed a quasi-U-shaped distribution in relation to BPA and decreased as TSH levels increased.</p>…”
-
7091
Supplementary file 1_Global, regional, and national total burden related to hepatitis B and attributable risk factors in adults aged 65 years and older from 1990 to 2021 and projec...
Published 2025“…ASIR and ASPR both showed significant decreasing trends in males and females, with persistently higher rates observed among males across all study years. …”
-
7092
Presentation 1_Genetic susceptibility to gestational diabetes and its mild modification by bisphenol A and thyroid-stimulating hormone: findings from a South Chinese pregnancy coho...
Published 2025“…The modification displayed a quasi-U-shaped distribution in relation to BPA and decreased as TSH levels increased.</p>…”
-
7093
Image 1_Genetic susceptibility to gestational diabetes and its mild modification by bisphenol A and thyroid-stimulating hormone: findings from a South Chinese pregnancy cohort.pdf
Published 2025“…The modification displayed a quasi-U-shaped distribution in relation to BPA and decreased as TSH levels increased.</p>…”
-
7094
Evolutionary tree analysis of ZmSTOMAGEN.
Published 2025“…To clarify the functional role of STOMAGEN orthologues in maize (<i>Zea mays</i>), we generated a double knockout mutant of ZmSTOMAGEN1 and ZmSTOMAGEN2 using CRISPR/Cas9 system. …”
-
7095
Data Sheet 8_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf
Published 2025“…</p>Methods<p>Using Global Burden of Disease 2021 data from 204 countries (1990-2021), we analyzed age-standardized mortality rates (ASMR) and disability-adjusted life years (DALY) for PMP-attributable LRIs, stratified by Socio-demographic Index (SDI), pollution source, and demographics. …”
-
7096
Data Sheet 5_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf
Published 2025“…</p>Methods<p>Using Global Burden of Disease 2021 data from 204 countries (1990-2021), we analyzed age-standardized mortality rates (ASMR) and disability-adjusted life years (DALY) for PMP-attributable LRIs, stratified by Socio-demographic Index (SDI), pollution source, and demographics. …”
-
7097
Data Sheet 1_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf
Published 2025“…</p>Methods<p>Using Global Burden of Disease 2021 data from 204 countries (1990-2021), we analyzed age-standardized mortality rates (ASMR) and disability-adjusted life years (DALY) for PMP-attributable LRIs, stratified by Socio-demographic Index (SDI), pollution source, and demographics. …”
-
7098
Data Sheet 7_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf
Published 2025“…</p>Methods<p>Using Global Burden of Disease 2021 data from 204 countries (1990-2021), we analyzed age-standardized mortality rates (ASMR) and disability-adjusted life years (DALY) for PMP-attributable LRIs, stratified by Socio-demographic Index (SDI), pollution source, and demographics. …”
-
7099
Data Sheet 3_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf
Published 2025“…</p>Methods<p>Using Global Burden of Disease 2021 data from 204 countries (1990-2021), we analyzed age-standardized mortality rates (ASMR) and disability-adjusted life years (DALY) for PMP-attributable LRIs, stratified by Socio-demographic Index (SDI), pollution source, and demographics. …”
-
7100
Video 2_Loss of two-pore channel 2 enhances CD8+ T cell cytotoxicity and directly impairs tumour growth via MAPK axis in HCC.mp4
Published 2025“…</p>Methods<p>To investigate the role of the endolysosomal two-pore channel 2 (TPC2) in HCC, we employed genetic and pharmacological approaches, including TPC2 knockout (KO) and pharmacological inhibition using SG094. …”